NIH and FDA announcements confirm Agilum’s April 7th Real-World Evidence (RWE) of COVID-19 drug treatment observations
DEERFIELD BEACH, Fla. — The National Institutes of Health (NIH) released a statement this week warning against the use of hydroxychloroquine (HCQ) in combination with azithromycin. This conclusion mirrors Agilum Healthcare Intelligence’s real-world evidence published two weeks earlier on April 7th. Agilum was also pleased that the U.S. Food and Drug Administration (FDA) issued a
